A pause in demand for home blood pressure monitors among large customers
First written in FY2024-Q2. 3 of 9 entries say "Worsened", first in FY2024-Q3. Latest entry: 2026-08-05.
No other company in this theme has enough history to compare yet.
- 2026-08-05MitigatedEarnings
「In Japan, demand for household blood pressure monitors for major customers and medical-use blood pressure monitors remained strong.」
Demand in Japan, including household blood pressure monitors for major customers, which had previously been weak, was described as strong. - FY2026Divergence in demand by regionAnnual report
「In Japan, revenue declined owing to weak demand for measuring instruments for medical institutions and the impact of changes in distribution channels for products supplied overseas. In the Americas, revenue increased as results for medical equipment supplied to major customers grew, along with the expansion of products compatible with healthcare digital transformation and sales channels for health equipment.」
While revenue in Japan declined owing to weak demand for products supplied to medical institutions and other factors, revenue in the Americas increased through growth in large-customer medical equipment, healthcare DX products and sales channels, with regional differences in demand continuing. - 2026-05-13OtherEarnings
「In Japan, sales declined because of weak demand for medical weighing equipment and the effect of changes in distribution channels for products sold overseas, which resulted in part of the business being recorded in other regions.」
In Japan's medical and healthcare equipment business, sales declined because of weak demand and changes in distribution channels, while sales increased in the Americas and Europe. - FY2026-H1WorsenedAnnual report
「In Japan, revenue and profit declined owing to weak demand for products supplied to major customers and for medical products, as well as the impact of changes in distribution channels for products supplied to certain customers.」
Weak demand for medical and health equipment in Japan, including home blood pressure monitors supplied to major customers, continued, while weak demand for medical products and the impact of changes in distribution channels also contributed to lower revenue and profit. - FY2025RestatedAnnual report
「In Japan, revenue declined because shipments of products to major customers remained sluggish and changes in distribution channels for products supplied to certain customers also had an impact. In the Americas, sales in local-currency terms fell below the previous year because demand for home blood pressure monitors struggled to grow, but sales after conversion into yen increased owing to foreign exchange effects.」
Shipments of products to major customers and demand for home blood pressure monitors in the Americas have remained sluggish. Meanwhile, sales in the Americas increased after foreign exchange translation, and sales in Europe also increased. - FY2025-H1WorsenedAnnual report
「In Japan, revenue declined as shipments to major customers remained sluggish, but profit increased owing to an improved product mix and higher productivity.」
Weak demand for medical and health equipment, including home blood pressure monitors supplied to major customers, continued, and revenue in Japan declined because shipments to major customers remained sluggish. - FY2024MitigatedAnnual report
「In the medical and health equipment business, demand for products for medical institutions and home use in Japan began to recover in the fourth quarter.」
Regarding the lull in and delayed recovery of demand for home blood pressure monitors from major customers, demand for products for medical institutions and home use in Japan began to recover in the fourth quarter. - FY2024-Q3WorsenedAnnual report
「In Japan, sales of medical products remained at approximately the previous year’s level, but both revenue and profit declined because the recovery in demand for home blood pressure monitors from major customers was delayed.」
For home blood pressure monitors supplied to major customers, the delay in demand recovery following the lull in the previous quarter continued to materialize as lower revenue and profit. - FY2024-Q2First statedAnnual report
「In Japan, demand for clinical blood pressure monitors for hospitals began to recover, but revenue declined due to a lull in demand for home blood pressure monitors from major customers.」
The lull in demand for home blood pressure monitors from major customers has materialized as lower revenue in Japan’s medical and health equipment business.